Product Information
LISINOPRIL 30 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0520 per EA under NDC 68180098202. Its NADAC has been published 488 times since May 31, 2017.
FDA first approved this application on Sep 9, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180098202
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077321FDA Approved
9/9/2005
TE Code
AB
On Market Since
4/17/2017
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL 30 MG TABLET has been published 488 times since May 31, 2017, and over the history we have for it it has declined 11.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0520 per EA |
|---|---|
| All-time high | $0.0709 (Aug 14, 2019) |
| All-time low | $0.0419 (Nov 20, 2024) |
| 52-week high | $0.0556 |
| 52-week low | $0.0520 |
| Median price | $0.0578 |
| Average price | $0.0584 |
| Largest weekly change | -25.1% (Nov 20, 2024) |
| Weeks tracked | 488 |
| Tracking since | May 31, 2017 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lisinopril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LISINOPRIL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL 30 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0520 per EA (NDC 68180098202), effective Sep 30, 2026.
How has the price of LISINOPRIL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for LISINOPRIL 30 MG TABLET has declined 11.9%. It has been tracked across 488 weekly CMS publications since May 31, 2017.
What are the highest and lowest recorded NADAC prices for LISINOPRIL 30 MG TABLET?
Since May 31, 2017, the NADAC for LISINOPRIL 30 MG TABLET has ranged from a low of $0.0419 (Nov 20, 2024) to a high of $0.0709 (Aug 14, 2019), with a median of $0.0578 per EA.
Are there cheaper alternatives to LISINOPRIL 30 MG TABLET?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LISINOPRIL 30 MG TABLET?
LISINOPRIL 30 MG TABLET (NDC 68180098202) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.